Equimolar oxygen-nitrous oxide (EMONO) in dental pediatric care: which patients achieve therapeutic effects? A French national exploratory prospective observational multicenter study
- PMID: 39548019
- DOI: 10.1007/s40368-024-00950-2
Equimolar oxygen-nitrous oxide (EMONO) in dental pediatric care: which patients achieve therapeutic effects? A French national exploratory prospective observational multicenter study
Abstract
Purpose: Equimolar oxygen-nitrous oxide mixture (EMONO) is considered as a reference for dental care in children. Completion of dental treatment has usually been used as a criterion to assess EMONO treatment. However, other patient-reported outcomes are needed. We sought to assess the prevalence of complete therapeutic effects (analgesia and anxiolysis) experienced by children during dental care under EMONO and identifying associated factors.
Methods: A national prospective observational multicentric study was conducted between September 2018 and June 2020 in 13 French university hospitals. Participants were children between 3 and 15 years of age requiring dental care under EMONO.
Results: 677 children were analyzed. Anxiolysis and analgesia were experienced by a large majority of patients (86.5% and 79.0%, respectively, and 73% experienced both effects). Several factors were associated with both analgesia and anxiolysis effects: the presence of expected effects (no loss of judgment and slight decrease in level of consciousness), the absence of agitation and distress, a positive perception of EMONO and ethnicity.
Conclusion: Most patients benefit from the therapeutic effects (anxiolysis and analgesia) expected by EMONO during dental treatment. It is reassuring to observe that most sociodemographic characteristics and medical history do not seem to influence the effectiveness of care. The study was registered at www.
Clinicaltrials: gov under the reference number NCT03453411.
Keywords: Analgesia; Anxiolysis; Nitrous oxide; Pediatric dentistry; Therapeutic effects.
© 2024. The Author(s), under exclusive licence to European Academy of Paediatric Dentistry.
Conflict of interest statement
Declarations. Conflict of interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Ethical approval: Informed oral consent and study conditions have been approved by the French Research Ethics Committee (CPP) on April 4th, 2018, and the study was conducted in accordance with the National Commission of Information Technology and Liberties (Commission Nationale de l’Informatique et des Libertés—CNIL) rules regarding data management and analysis. Patient consent: Written information was adapted to the age of the children, and all of them and their legal representative provided informed oral consent to participate in accordance with the Declaration of Helsinki.
References
-
- American Academy of Pediatric Dentistry. Guideline on Use of Nitrous Oxide for Pediatric Dental Patients. 2013. [accessed 08/30/2021].
-
- ANSM. 2021. Base de données publique des médicaments. [accessed 08/30/2021]..
-
- Ashley PF, Chaudhary M, Lourenço-Matharu L. Sedation of children undergoing dental treatment. Cochrane Database of Syst Rev. 2018. https://doi.org/10.1002/14651858.CD003877.pub5 . - DOI
-
- Atash R, Vanden AA. Sedation with 50 % nitrous oxide/oxygen in paediatric dentistry. Rev Med Brux. 2008;29(4):257–61. - PubMed
-
- Brunick A, Clark MS. Nitrous oxide and oxygen sedation: an update. Dent Assist. 2013;82(4):12 4–6, 8–9; quiz 20–1.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
